1. Home
  2. KHC vs ILMN Comparison

KHC vs ILMN Comparison

Compare KHC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Kraft Heinz Company

KHC

The Kraft Heinz Company

HOLD

Current Price

$23.89

Market Cap

26.6B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$144.76

Market Cap

21.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KHC
ILMN
Founded
1869
1998
Country
United States
United States
Employees
N/A
8650
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6B
21.8B
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
KHC
ILMN
Price
$23.89
$144.76
Analyst Decision
Hold
Hold
Analyst Count
17
17
Target Price
$24.50
$124.24
AVG Volume (30 Days)
13.1M
1.6M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
7.14%
N/A
EPS Growth
N/A
170.87
EPS
0.67
0.87
Revenue
$24,942,000,000.00
$4,343,000,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
$0.58
$5.58
P/E Ratio
$35.21
$166.20
Revenue Growth
N/A
N/A
52 Week Low
$21.04
$78.80
52 Week High
$29.19
$155.53

Technical Indicators

Market Signals
Indicator
KHC
ILMN
Relative Strength Index (RSI) 62.14 62.98
Support Level $23.55 $116.54
Resistance Level $24.59 $152.36
Average True Range (ATR) 0.69 5.32
MACD 0.06 0.04
Stochastic Oscillator 86.89 65.04

Price Performance

Historical Comparison
KHC
ILMN

About KHC The Kraft Heinz Company

In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: